Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Acadia Healthcare Company, Inc. (ACHC) SEC Filings & Earnings Calls

EquiReason read 20 Acadia Healthcare Company, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-09-25 — Acadia Healthcare disclosed preliminary approval of a settlement in stockholder derivative actions related to previously settled securities litigation. The settlement is subject to.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ACHCAcadia Healthcare Company, Inc.Follow ACHC — free
Medical Care Facilities · Healthcare
—
Price chart with a free account
Market cap
2.9B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days

Every filing, read

last 12 months · SEC

What happened, the numbers inside, guidance and risks. The original is one click away.

25 Sep 20268-K · 8.01Acadia Healthcare disclosed preliminary approval of a settlement in stockholder derivative actions related to previously settled securities litigation. The settlement is subject to final court approval.open

Risks flagged

Settlement of derivative litigation may involve governance changes or costs, but terms not disclosed.

“Stipulation of Settlement dated July 31, 2026” · word for word
Read the original on SEC EDGAR ↗
28 Jul 20268-K · 2.02, 7.01Revenue $866M (+0% y/y); Adjusted EBITDA $149M (-26% y/y); Adjusted EPS $0.38 (-54% y/y); Guidance: Full year 2026 financial and cash flow guidance updated downwardearningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$866M0% y/y
Adjusted EBITDA · Q2-2026$149M-26% y/y
Adjusted EPS · Q2-2026$0.38-54% y/y
Same-facility patient days growth · Q2-20260.8%
Same-facility revenue per patient day growth · Q2-2026-0.8%
Operating cash flow · Q2-2026$162M+21% y/y
Capital expenditures · Q2-2026$39M-77% y/y
Licensed beds added · Q2-2026240

Guidance

Full year 2026 financial and cash flow guidance updated downward

Full year 2026 guidance cut; management tone positive citing operational execution and capacity expansion.

Risks flagged

Legal reserve adjustment of $28.6M significantly impacted earnings; potential for further adjustments.

“$28.6 million adjustment to professional and general liability reserves.” · word for word

Revenue flat despite capacity expansion; supplemental payment program timing creates volatility.

“Total revenue flat YoY; normalized growth 2.8% after adjusting for supplemental payments.”
Read the original on SEC EDGAR ↗
28 Jul 202610-QAcadia Healthcare reported Q2 2026 revenue decline and significant net income drop due to labor cost pressure and higher operating expenses.earningsopen

Figures in the filing · each found in the filing text

Revenue · Q2-2026$866M-0% y/y
Net income attributable to Acadia Healthcare Company, Inc. · Q2-2026$11M-64% y/y
Same facility revenue growth · Q2-2026-0.1%
Same facility patient days growth · Q2-20260.8%
Same facility admissions growth · Q2-20266.4%
Same facility average length of stay change · Q2-2026-5.3%
Same facility revenue per patient day growth · Q2-2026-0.8%
Salaries, wages and benefits as % of revenue · Q2-202654.8%
Other operating expenses as % of revenue · Q2-202618.0%
Bed count · 2026-06-3012,600

Risks flagged

Medicaid reimbursement risk

“The OBBBA reduces the federal government’s overall Medicaid expenditures and tightens Medicaid eligibility requirements.” · word for word

Labor cost pressure

“Similar to many other healthcare providers and other industries across the country, we have been navigating a tight labor market.” · word for word

Legal and regulatory risk

“Government investigations include legal fees and settlement costs related to certain litigation, including the matters referenced in Note 8 – Commitments and Contingencies in the accompanying notes to our condensed consolidated financial statements.” · word for word
Read the original on SEC EDGAR ↗
18 May 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement)open

Risks flagged

Jury verdict of $105M in employment lawsuit; company intends to appeal but outcome uncertain.

“Jury awarded $35M compensatory and $70M punitive damages.”
Read the original on SEC EDGAR ↗
30 Apr 202610-QRevenue $829M (+8% y/y); Net income attributable to Acadia Healthcare Company, Inc. $4M (-51% y/y); Operating cash flow $62M (+435% y/y)open

Figures in the filing · each found in the filing text

Revenue · Q1-2026$829M+8% y/y
Net income attributable to Acadia Healthcare Company, Inc. · Q1-2026$4M-51% y/y
Operating cash flow · Q1-2026$62M+435% y/y
Bed count · 2026-03-3112,400
Facility count · 2026-03-31275
Cash and cash equivalents · 2026-03-31$159M
Same facility revenue growth · Q1-20267.3%
Same facility patient days growth · Q1-20261.6%
Same facility admissions growth · Q1-20266.5%
Same facility average length of stay change · Q1-2026-4.6%

Risks flagged

Medicaid reimbursement reduction from OBBBA

“The OBBBA reduces the federal government’s overall Medicaid expenditures and tightens Medicaid eligibility requirements.” · word for word

Elevated legal and investigation costs

“Government investigations include legal fees and settlement costs related to certain litigation, including the matters referenced in Note 8 — Commitments and Contingencies.” · word for word

Labor cost inflation

“Salaries, wages and benefits expense was $467.0 million for the three months ended March 31, 2026 compared to $445.3 million for the three months ended March 31, 2025, an increase of $21.7 million.”

High leverage and interest expense

“Interest expense was $38.3 million for the three months ended March 31, 2026 compared to $29.2 million for the three months ended March 31, 2025. The increase in interest expense was primarily the result of increased borrowings.” · word for word
Read the original on SEC EDGAR ↗
29 Apr 20268-K · 2.02, 7.01Released earnings results and quarterly financials; issued a Regulation FD disclosure (forward guidance or material update)earningsopen

Risks flagged

Regulatory risk from OBBBA Medicaid changes

“Risk factor mentions OBBBA enacted July 4, 2025, introducing work requirements in Medicaid expansion population”

Labor cost pressure

“Risk factor mentions increased costs relating to labor”
Read the original on SEC EDGAR ↗
23 Apr 20268-K · 5.02, 7.01Base salary $100,000.00; quarterly cash bonus $125,000.00; severance payment $350,000.00open

Figures in the filing · each found in the filing text

base salary · point_in_time$100000.00
quarterly cash bonus · point_in_time$125000.00
severance payment · point_in_time$350000.00

Risks flagged

CFO transition risk

“Departure of CFO and appointment of interim CFO; Duckworth has prior company experience reducing risk”
Read the original on SEC EDGAR ↗
25 Mar 2026DEF 14ARevenue $3.22B; Net Income (Loss) $-1.10B; Adjusted EBITDA $612M (-14% y/y)open

Figures in the filing · each found in the filing text

Revenue · FY2025$3.22B
Net Income (Loss) · FY2025$-1.10B
Adjusted EBITDA · FY2025$612M-14% y/y
Bed Count · FY202512,500
Facility Count · FY2025277
Goodwill Impairment · FY2025$996M
Legal Settlements Expense · FY2025$151M

Risks flagged

Litigation Risk

“Legal settlements expense (d) 150,966” · word for word

Goodwill Impairment Risk

“the amount for the year ended December 31, 2025 includes a non-cash goodwill impairment charge of $996.2 million.” · word for word

Regulatory/Government Investigation Risk

“Transaction, legal and other costs (b) 163,630” · word for word
Read the original on SEC EDGAR ↗
12 Mar 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open

Risks flagged

No material risk; board transition is routine.

“No disagreement with company; no material changes to operations.”
Read the original on SEC EDGAR ↗
27 Feb 202610-KRisks named: Medicaid/ACA policy risk, High leverage risk, Labor cost inflationopen

Risks flagged

Medicaid/ACA policy risk

“The OBBBA reduces federal Medicaid expenditures and tightens beneficiary eligibility requirements... marketplace premiums have increased substantially, and enrollment for the 2026 plan year declined significantly.” · word for word

High leverage risk

“At December 31, 2025, we had approximately $2.5 billion of total debt” · word for word

Labor cost inflation

“A shortage of nurses, qualified addiction counselors and other medical and care support personnel... has been a significant operating issue” · word for word
Read the original on SEC EDGAR ↗
25 Feb 20268-K · 2.02, 7.01Released earnings results and quarterly financials; issued a Regulation FD disclosure (forward guidance or material update)earningsopen

Risks flagged

OBBBA introduces work requirements for Medicaid expansion, potentially reducing patient volumes and revenue.

“OBBBA’s introduction of work or community engagement requirements in the Medicaid expansion population” · word for word

Integration risk from acquisitions and facility expansions.

“potential difficulties in successfully integrating the operations of acquired facilities” · word for word

Litigation and regulatory actions could impact stock price and operations.

“occurrence of patient incidents, governmental investigations, litigation and adverse regulatory actions” · word for word
Read the original on SEC EDGAR ↗
23 Jan 2026SC 13D/ASchedule 13D/A: Khrom Investments Fund, LP 8.81%SEC ↗
23 Jan 20268-K · 5.02Retention bonus cash payment $2Mopen

Figures in the filing · each found in the filing text

retention bonus cash payment · 2026$2M

Risks flagged

CEO departure creates leadership uncertainty and potential strategic disruption.

“CEO Christopher Hunter departed effective January 20, 2026; separation agreement includes significant cash payments.”
Read the original on SEC EDGAR ↗
20 Jan 20268-K · 5.02, 7.01CEO base salary $1Mopen

Figures in the filing · each found in the filing text

CEO base salary · FY2026$1M

Risks flagged

Leadership transition risk; new CEO may implement strategic changes.

“New CEO appointment with employment agreement.”
Read the original on SEC EDGAR ↗
13 Jan 20268-K · 2.02, 7.01Released earnings results and quarterly financials; issued a Regulation FD disclosure (forward guidance or material update)earningsSEC ↗
2 Dec 20258-K · 7.01Adjusted EBITDA guidance $601M; Adjusted EPS guidance $1.94; PLGL expense $116M (+115% y/y); Guidance: Adjusted EBITDA reduced by $49M to $601-611M; EPS reduced by $0.41 to $1.94-2.04open

Figures in the filing · each found in the filing text

Adjusted EBITDA guidance · FY2025$601M
Adjusted EPS guidance · FY2025$1.94
PLGL expense · FY2025$116M+115% y/y
Net PLGL liability at year-end 2025 · FY2025$145M
PLGL expense 2026 guidance · FY2026$100M

Guidance

Adjusted EBITDA reduced by $49M to $601-611M; EPS reduced by $0.41 to $1.94-2.04

Guidance cut driven entirely by PLGL expense increase; no demand or revenue weakness indicated.

Risks flagged

Litigation liability pressure: patient-related claims driving significant PLGL expense increase; 168% claim frequency increase; less favorable reinsurance.

“Higher expected settlement costs for claims related to policy years prior to September 1, 2024; A 168% increase in claim frequency during the 2025 policy year; Less favorable reinsurance coverage terms versus prior years.” · word for word
Read the original on SEC EDGAR ↗
24 Nov 2025SC 13D/ASchedule 13D/A: Khrom Investments Fund, LP 7.74%SEC ↗
10 Nov 20258-K · 7.01Acadia Healthcare agreed to settle securities litigation for $179M, with $30M expected from insurance. Settlement has no impact on adjusted EBITDA or financial guidance. Company maintains strong liquidity with $118.7M cash and $786.7M revolopen

Figures in the filing · each found in the filing text

Cash and cash equivalents · Q3-2025$119M
Revolving credit facility availability · Q3-2025$787M
Consolidated Total Net Leverage Ratio · Q3-2025$3.40

Guidance

Settlement has no impact on previously announced financial guidance; company affirms strong financial position.

Risks flagged

Securities litigation settlement of $179M creates a material cash outflow, though partially offset by insurance and strong liquidity.

“Acadia agreed to pay an aggregate amount of $179 million as the monetary component of the settlement.” · word for word
Read the original on SEC EDGAR ↗
5 Nov 202510-QRevenue $852M (+4% y/y); Net income attributable to Acadia $36M (-47% y/y); Bed count 12,500open

Figures in the filing · each found in the filing text

Revenue · Q3-2025$852M+4% y/y
Net income attributable to Acadia · Q3-2025$36M-47% y/y
Bed count · 2025-09-3012,500
Facility count · 2025-09-30278
Same facility revenue growth · Q3-20253.7%
Same facility patient days growth · Q3-20251.3%
Operating cash flow · 9M-2025$218M+1578% y/y
Cash and cash equivalents · 2025-09-30$119M

Risks flagged

Elevated legal and investigation costs

“Government investigation costs $38.7M in Q3 2025 vs $3.1M in prior year.”

Labor cost pressure

“SWB as % of revenue increased from 51.3% to 53.6%.”

Medicaid policy changes

“OBBBA includes restrictions on provider tax arrangements starting 2028.”
Read the original on SEC EDGAR ↗
5 Nov 20258-K · 2.02, 5.02Revenue $852M (+4% y/y); Same facility revenue growth 3.7; Patient days growth 1.3; Guidance: Revenue guidance lowered to $3.28-3.30B from $3.30-3.35B; Adjusted EBITDA to $650-660M from $675-700M; Adjusted EPS to $2.35-2.45 from $2.45-2.65earningsopen

Figures in the filing · each found in the filing text

Revenue · Q3-2025$852M+4% y/y
Same facility revenue growth · Q3-20253.7%
Patient days growth · Q3-20251.3%
Net income attributable to Acadia · Q3-2025$36M-46% y/y
Adjusted EBITDA · Q3-2025$173M-11% y/y
Adjusted income attributable to Acadia · Q3-2025$65M-21% y/y
Revenue guidance · FY2025$3.29B

Guidance

Revenue guidance lowered to $3.28-3.30B from $3.30-3.35B; Adjusted EBITDA to $650-660M from $675-700M; Adjusted EPS to $2.35-2.45 from $2.45-2.65

Lowered full-year guidance due to volume/rate pressure, bad debt, and PLGL costs; reducing capex to improve free cash flow.

Risks flagged

Persistent volume and rate pressure from Medicaid and payor scrutiny.

“Persistent softness in acute care Medicaid volumes and heightened payor scrutiny around authorizations.” · word for word

Elevated bad debt and denials expected to continue in Q4.

“Revenue was negatively impacted by elevated levels of bad debt and denials, which are expected to remain a headwind in the fourth quarter.” · word for word

Higher PLGL costs with incremental $4-6M expected in Q4.

“Revised outlook incorporates an incremental assumption on PLGL charges of $4.0 million to $6.0 million that are now expected in the fourth quarter.” · word for word

Startup losses from new facilities increasing.

“Startup losses from newly opened facilities totaled $13.3 million in the quarter, up from $7.3 million in the third quarter of 2024.” · word for word
Read the original on SEC EDGAR ↗

Acadia Healthcare Company, Inc. — questions

What did Acadia Healthcare Company, Inc. file recently?
20 SEC filings in the last 12 months. Latest: 8-K on 2026-09-25 — Acadia Healthcare disclosed preliminary approval of a settlement in stockholder derivative actions related to previously settled securities litigation. The settlement is subject to final court approval.

Every figure on this page comes from Acadia Healthcare Company, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.